Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 01:05 | 2026-02-26 | EDSA | Edesa Biotech, Inc. | Nijhawan Pardeep | Director, Officer, 10% owner | BUY | $1.96 | 50,571 | $99,175 | 371,702 |
| 2026-03-03 01:06 | 2026-02-26 | JAZZ | Jazz Pharmaceuticals plc | Patil Neena M | Officer | OPT+S | $191.56 | 55,600 | $10,650,480 | 58,818 |
| 2026-03-03 00:34 | 2026-02-26 | NUVL | Nuvalent, Inc. | Noci Darlene | Officer | OPT+S | $103.03 | 5,500 | $566,682 | 58,117 |
| 2026-03-03 00:22 | 2026-02-26 | BCAX | Bicara Therapeutics Inc. | RA CAPITAL MANAGEMENT, L.P. | Director, 10% owner | BUY | $16.00 | 300,000 | $4,800,000 | 4,603,418 |
| 2026-03-03 00:08 | 2026-02-27 | ALNY | Alnylam Pharmaceuticals Inc. | Garg Pushkal | Officer | OPT+S | $331.34 | 4,627 | $1,533,100 | 22,129 |
| 2026-03-03 00:10 | 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | Officer | SELL | $483.36 | 357 | $172,560 | 6,624 |
| 2026-03-02 22:16 | 2026-02-27 | ABCL | AbCellera Biologics Inc. | Thermopylae Holdings Ltd. | 10% owner | BUY | $3.44 | 38,000 | $130,720 | 56,134,097 |
| 2026-03-02 17:15 | 2026-02-27 | FBLG | FibroBiologics, Inc. | GARCIA RUBEN A | Officer | BUY | $0.33 | 40,000 | $13,056 | 180,000 |
| 2026-03-02 16:00 | 2026-02-27 | PVLA | PALVELLA THERAPEUTICS, INC. | HERON ELAINE J | Director | BUY | $125.00 | 2,400 | $300,000 | 47,812 |
| 2026-03-02 16:00 | 2026-02-27 | PVLA | PALVELLA THERAPEUTICS, INC. | JENKINS GEORGE M | Director | BUY | $125.00 | 4,000 | $500,000 | 187,171 |
| 2026-02-28 00:11 | 2026-02-26 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Officer | SELL | $66.00 | 2,000 | $132,000 | 121,945 |
| 2026-02-28 00:20 | 2026-02-26 | ABCL | AbCellera Biologics Inc. | Thermopylae Holdings Ltd. | 10% owner | BUY | $3.27 | 177,457 | $580,284 | 56,096,097 |
| 2026-02-28 00:42 | 2026-02-25 | QURE | uniQure N.V. | KLEMT CHRISTIAN | Officer | SELL | $23.86 | 6,217 | $148,338 | 211,513 |
| 2026-02-28 01:00 | 2026-02-25 | ABBV | AbbVie Inc. | Siatis Perry C | Officer | OPT+S | $230.00 | 22,381 | $5,147,630 | 38,137 |
| 2026-02-28 00:44 | 2026-02-05 | MANE | Veradermics, Inc | CHILDS JOHN W | Director | BUY | $17.00 | 294,117 | $4,999,989 | 294,117 |
| 2026-02-28 05:00 | 2026-02-26 | WVE | Wave Life Sciences Ltd. | Francis Chris | Officer | OPT+S | $15.05 | 33,194 | $499,593 | 61,867 |
| 2026-02-28 02:54 | 2026-02-25 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Officer | SELL | $12.77 | 54,345 | $694,208 | 132,873 |
| 2026-02-28 03:00 | 2026-02-25 | QTTB | Q32 Bio Inc. | Violette Shelia M. | Officer | SELL | $4.51 | 2,815 | $12,708 | 55,569 |
| 2026-02-28 03:00 | 2026-02-25 | QTTB | Q32 Bio Inc. | Morrison Jodie Pope | Director, Officer | SELL | $4.51 | 9,896 | $44,675 | 89,104 |
| 2026-02-28 03:00 | 2026-02-26 | AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Officer | OPT+S | $161.88 | 35,378 | $5,726,991 | 0 |
| 2026-02-28 03:00 | 2026-02-26 | AXSM | Axsome Therapeutics, Inc. | Coleman Mark | Director | SELL | $161.11 | 25,000 | $4,027,750 | 47,140 |
| 2026-02-28 03:00 | 2026-02-25 | QTTB | Q32 Bio Inc. | Kalowski Lee | Officer | SELL | $4.51 | 3,995 | $18,035 | 35,943 |
| 2026-02-28 01:19 | 2026-02-27 | BHC | Bausch Health Companies Inc. | Carson Seana | Officer | SELL | $5.95 | 8,388 | $49,909 | 809,258 |
| 2026-02-28 00:49 | 2026-02-25 | IRON | Disc Medicine, Inc. | Franchi Jean M. | Officer | SELL | $69.06 | 353 | $24,377 | 70,990 |
| 2026-02-28 00:49 | 2026-02-25 | QURE | uniQure N.V. | Kapusta Matthew C | Director, Officer | SELL | $23.86 | 12,378 | $295,339 | 639,076 |
| 2026-02-28 00:13 | 2026-02-25 | BCAX | Bicara Therapeutics Inc. | Cohlhepp Ryan | Director, Officer | OPT+S | $18.04 | 3,631 | $65,501 | 209,641 |
| 2026-02-28 00:05 | 2026-02-25 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Director | SELL | $7.01 | 50,000 | $350,255 | 154,657 |
| 2026-02-27 22:48 | 2026-02-27 | ABCL | AbCellera Biologics Inc. | Booth Andrew | Officer | BUY | $3.42 | 42,600 | $145,692 | 195,600 |
| 2026-02-27 16:33 | 2026-02-25 | LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | BUY | $1.49 | 2,000 | $2,980 | 1,906,186 |
| 2026-02-27 00:40 | 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Stengone Carmine N. | Director, Officer | OPT+S | $16.02 | 7,100 | $113,728 | 14,954 |
| 2026-02-27 00:39 | 2026-02-24 | CTNM | Contineum Therapeutics, Inc. | Lorrain Daniel S. | Officer | OPT+S | $16.02 | 8,124 | $130,164 | 156,052 |
| 2026-02-27 05:40 | 2026-02-24 | NAMS | NewAmsterdam Pharma Co N.V. | Davidson Michael H. | Director, Officer | OPT+S | $34.53 | 306,293 | $10,575,103 | 174,144 |
| 2026-02-27 04:39 | 2026-02-26 | BMRN | BIOMARIN PHARMACEUTICAL INC | Friberg Gregory R | Officer | SELL | $60.38 | 6,326 | $381,937 | 37,578 |
| 2026-02-27 04:31 | 2026-02-26 | BMRN | BIOMARIN PHARMACEUTICAL INC | Davis George Eric | Officer | SELL | $61.36 | 26,061 | $1,599,103 | 72,453 |
| 2026-02-27 03:09 | 2026-02-24 | PAHC | PHIBRO ANIMAL HEALTH CORP | BENDHEIM JACK | Director, Officer, 10% owner | SELL | $52.27 | 21,120 | $1,103,938 | 1,480 |
| 2026-02-27 02:55 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | Officer | SELL | $486.35 | 260 | $126,451 | 46,763 |
| 2026-02-27 02:48 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | McKechnie Duncan | Officer | SELL | $487.65 | 4,910 | $2,394,365 | 17,559 |
| 2026-02-27 02:50 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | Officer | SELL | $486.35 | 1,846 | $897,802 | 55,570 |
| 2026-02-27 01:56 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | Officer | SELL | $486.35 | 223 | $108,456 | 6,981 |
| 2026-02-27 02:00 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | Officer | SELL | $486.35 | 668 | $324,882 | 18,432 |
| 2026-02-27 02:01 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | Officer | SELL | $486.35 | 945 | $459,601 | 13,659 |
| 2026-02-27 02:06 | 2026-02-25 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Bunnage Mark E. | Officer | SELL | $486.35 | 620 | $301,537 | 7,284 |
| 2026-02-27 00:47 | 2026-02-24 | ORIC | Oric Pharmaceuticals, Inc. | Piscitelli Dominic | Officer | OPT+S | $13.51 | 52,000 | $702,686 | 68,148 |
| 2026-02-26 00:00 | 2026-02-23 | AMLX | Amylyx Pharmaceuticals, Inc. Common Stock | Mazzariello Gina | Officer | SELL | $14.14 | 3,419 | $48,352 | 141,274 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Martini Gregory S. | Officer | SELL | $3.73 | 21,944 | $81,888 | 160,601 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | John Minardo | Officer | SELL | $3.73 | 36,492 | $136,177 | 363,886 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Shetzline Michael | Officer | SELL | $3.73 | 32,582 | $121,586 | 521,425 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gaskins Tammi L | Officer | SELL | $3.73 | 21,526 | $80,329 | 213,738 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | MCCOURT Thomas A | Director, Officer | SELL | $3.73 | 198,283 | $739,933 | 1,489,002 |
| 2026-02-26 00:05 | 2026-02-23 | IRWD | IRONWOOD PHARMACEUTICALS INC | Silver Ronald | Officer | SELL | $3.73 | 24,173 | $90,206 | 252,636 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.